Zhejiang Pharmaceutical Ltd. announced recently it signed a long term supply contract with Hospira of US for Vancomycin with a period between April 30, 2008 and December 31, 2017.

Total contract value is around US$120 million or CNY 840 million. The contract is expected to bring CNY 84 million in annual sales and over CNY 20 million in annual profits to Zhejiang Pharma.